Asia Green Biotechnology Corp. Announces Grant of Application for Management Cease Trade Order
Asia Green Biotechnology Corp. Announces Grant of Application for Management Cease Trade Order
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES
不用於分發給美國新聞通訊社或在美國傳播
CALGARY, AB / ACCESSWIRE / May 8, 2024 / Asia Green Biotechnology Corp. ("Asia Green" or the "Company") (CSE:ASIA) announces that, further to its news releases dated April 17, 2024 and April 26, 2024, the Alberta Securities Commission ("ASC") has granted the Company's application for the issuance of a Management Cease Trade Order ("MCTO").
艾伯塔省卡爾加里/ACCESSWIRE/2024年5月8日/亞洲綠色生物技術公司（“Asia Green” 或 “公司”）（CSE: ASIA）宣佈，繼2024年4月17日和2024年4月26日發佈的新聞稿之後，艾伯塔省證券委員會（“ASC”）批准了該公司發佈管理停止交易令（“MCTO”）的申請。
The MCTO prohibits the CEO and CFO of the Company from trading in the securities of the Company until such time as it has filed the following continuous disclosure documents (collectively, the "Documents"):
MCTO禁止公司首席執行官和首席財務官在公司提交以下持續披露文件（統稱爲 “文件”）之前交易公司的證券：
- the Company's Annual Audited Financial Statements for the year ended December 31, 2023, as required by section 4.2 of National Instrument 51-102 - Continuous Disclosure Obligations ("NI 51-102"); and
- the Company's Management Discussion & Analysis for the year ended December 31, 2023, as required by section 5.1(2) of NI 51-102.
- CEO and CFO certificates relating to the Audited Annual Financial Statements, as required by NI 52-109.
- 根據國家儀器51-102第4.2節的要求，公司截至2023年12月31日止年度的年度經審計的財務報表- 持續披露義務 （“NI 51-102”）；以及
- 根據NI 51-102第5.1（2）節的要求，公司截至2023年12月31日止年度的管理層討論與分析。
- 根據NI 52-109的要求，與經審計的年度財務報表相關的首席執行官和首席財務官證書。
The Corporation is still working with its auditors and expects that the Documents will be filed by May 27, 2024, and that interim Q1 financial statements will be filed by May 30, 2024.
該公司仍在與核數師合作，預計文件將在2024年5月27日之前提交，第一季度中期財務報表將在2024年5月30日之前提交。
During this period of default, the Company will continue to satisfy the provisions of the alternative information guidelines as required by National Policy 12-203 - Management Cease Trade Orders.
在這段違約期間，公司將繼續按照國家政策12-203-的要求遵守替代信息指導方針的規定 管理層停止交易訂單。
Asia Green confirms that, other than as disclosed in prior press releases and material change reports, there have been no material business developments since the filing on November 29, 2023, of the Company's latest interim financial reports for the three-and-nine-month periods ended September 30, 2023.
Asia Green證實，除了先前的新聞稿和重大變動報告中披露的那樣，自2023年11月29日提交公司截至2023年9月30日的三至九個月期間的最新中期財務報告以來，沒有任何重大業務發展。
For further information, contact:
欲了解更多信息，請聯繫：
Asia Green Biotechnology Corp.
David Pinkman (CEO)
T: 403 863-6034
E: david.pinkman@asiagreenbiotechnology.com
亞洲綠色生物技術公司
大衛平克曼（首席執行官）
電話：403 863-6034
E: david.pinkman@asiagreenbiotechnology.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所風險投資交易所及其監管服務提供商（該術語在多倫多證券交易所風險交易所的政策中定義）均不對本新聞稿的充分性或準確性承擔責任。
Caution Regarding Forward-Looking Information Forward-looking statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. Forward-looking statements are often, but not always, identified by words such as "believes", "may", "likely", "plans", or similar words. Forward- looking statements included in this news release include statements with respect to activities in Zimbabwe. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Corporation, including, but not limited to the impact of general economic conditions, industry conditions, currency fluctuations, and dependence upon regulatory approvals. The Corporation does not assume any obligation to update the forward-looking statements to reflect changes in assumptions or circumstances other than as required by applicable law.
前瞻性信息注意前瞻性陳述——本新聞稿中列出的某些信息可能包含涉及大量已知和未知風險和不確定性的前瞻性陳述。前瞻性陳述通常以 “相信”、“可能”、“可能”、“計劃” 或類似詞語來識別，但並非總是如此。本新聞稿中包含的前瞻性聲明包括有關津巴布韋活動的聲明。這些前瞻性陳述受到許多風險和不確定性的影響，其中一些風險和不確定性是公司無法控制的，包括但不限於總體經濟狀況、行業狀況、貨幣波動和對監管批准的依賴的影響。除適用法律要求外，公司不承擔任何義務更新前瞻性陳述以反映假設或情況的變化。
SOURCE: Asia Green Biotechnology Corp.
來源：亞洲綠色生物技術公司
譯文內容由第三人軟體翻譯。